You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 13, 2025

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
Published on: December 23, 2022
Po Li1, Xueying Lei2, Xiaoying Niu1
1Department of Orthopedic and Soft Tissue, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
A novel CRISPR/Cas12a biosensing platform offers label-free microRNA (miRNA) detection. This innovative system simplifies diagnostics, enhancing accuracy and selectivity for point-of-care applications.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: